Publications by authors named "David J Mutimer"

Claim this Profile
H
Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure.
Teegan R Lim, Jonathan M Hazlehurst, Andrei I Oprescu, Matthew J Armstrong, Sewa F Abdullah, David J Mutimer

Clin Endocrinol (Oxf)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.
Graham R Foster, Kosh Agarwal, Matthew E Cramp, Sulleman Moreea, Stephen Barclay, David J Mutimer

Hepatology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.
Michelle C M Cheung, Alex J Walker, Benjamin E Hudson, Suman Verma, John McLauchlan, David J Mutimer

J Hepatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.
Graham R Foster, William L Irving, Michelle C M Cheung, Alex J Walker, Benjamin E Hudson, David J Mutimer

J Hepatol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.
Ian A Rowe, Damien C Tully, Matthew J Armstrong, Richard Parker, Kathy Guo, David J Mutimer

Liver Transpl· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the quality of clinical practice guidelines for clinicians and patients.
Ian A Rowe, Richard Parker, Matthew J Armstrong, Andrew L King, Diarmaid D Houlihan, David J Mutimer

Hepatology· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.
Roeland Zoutendijk, Jurrien G P Reijnders, Fabien Zoulim, Ashley Brown, David J Mutimer

Gut· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercurrent infection predicts mortality in patients with late hepatic artery thrombosis listed for liver retransplantation.
Joanna Agnes Leithead, Matthew R Smith, Luke B Materacki, Vandana M Sagar, Bridget K Gunson, David J Mutimer

Liver Transpl· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid recovery of cytochrome P450 3A4 after protease inhibitor withdrawal in post-liver transplant patients.
Ye Htun Oo, David J Mutimer

Liver Transpl· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis A virus vaccination in persons with hepatitis C virus infection: consequences of quality measure implementation.
Ian A Rowe, Richard Parker, Matthew J Armstrong, Diarmaid D Houlihan, David J Mutimer

Hepatology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of HBV- and HCV-induced end stage liver disease.
David J Mutimer, Anna Lok

Gut· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?
Diarmaid D Houlihan, Matthew J Armstrong, Yana Davidov, James Hodson, Peter Nightingale, David J Mutimer

Liver Transpl· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease inhibitors for treatment of genotype 1 hepatitis C virus infection.
Ian A Rowe, David J Mutimer

BMJ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure.
Sheldon C Cooper, Roland C Aldridge, Tahir Shah, Kerry Webb, Peter Nightingale, David J Mutimer

Liver Transpl· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.
Dennis A Freshwater, Tracey Dudley, Patricia Cane, David J Mutimer

Transplantation· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after liver transplantation for hepatitis C infection.
Tracey Dudley, Dawn Chaplin, Collette Clifford, David John Mutimer

Qual Life Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.
David J Mutimer, Bridget Gunson, John Chen, J Berenguer, Peter Neuhaus

Transplantation· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients.
Alan J Wigg, Bridget K Gunson, David J Mutimer

Liver Transpl· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B and C virus infections in the immune compromised.
Geoffrey H Haydon, David J Mutimer

Curr Opin Infect Dis· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Mohamed H Wali, Mathis Heydtmann, Rebecca F Harrison, Bridget K Gunson, David J Mutimer

Liver Transpl· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically modified interferon: is there a consensus yet?
Geoffrey H Haydon, David J Mutimer

Eur J Gastroenterol Hepatol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis